Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients' data.
about
Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients' data.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Surrogate endpoint for overall ...... of individual patients' data.
@en
Surrogate endpoint for overall ...... of individual patients' data.
@nl
type
label
Surrogate endpoint for overall ...... of individual patients' data.
@en
Surrogate endpoint for overall ...... of individual patients' data.
@nl
prefLabel
Surrogate endpoint for overall ...... of individual patients' data.
@en
Surrogate endpoint for overall ...... of individual patients' data.
@nl
P2093
P2860
P356
P1433
P1476
Surrogate endpoint for overall ...... of individual patients' data.
@en
P2093
Da-Peng Yang
Hong-Bo Huan
Liang Zhang
Wan-Yee Lau
Xi-Shu Wang
Xu-Dong Wen
P2860
P304
90291-90300
P356
10.18632/ONCOTARGET.18853
P407
P577
2017-06-29T00:00:00Z